Seminoma staging

Jump to navigation Jump to search

Seminoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seminoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

TNM
Stage Grouping

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Treatment - Stage I
Treatment - Stage II
Treatment - Stage III
Treatment - Recurrent

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seminoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seminoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seminoma staging

CDC on Seminoma staging

Seminoma staging in the news

Blogs on Seminoma staging

Directions to Hospitals Treating Seminoma

Risk calculators and risk factors for Seminoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Staging

The American Joint Committee on Cancer (AJCC) includes serum tumor marker levels in the stages for germ cell tumors, including seminoma. S describes the levels of serum tumour markers in the blood after orchiectomy. The serum tumor markers measured are alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH).[1]

S Serum tumor marker levels
SX Tumor marker levels are not available or have not been measured.
S0 Tumor marker levels are normal.
S1 All tumor marker levels are above normal.
  • AFP is less than 1,000 ng/mL.
  • HCG is less than 5,000 mIU/mL.
  • LDH is less than 1.5 times the upper limit of the normal range.
S2 At least one tumor marker level is high.
  • AFP is between 1,000 and 10,000 ng/mL.
  • HCG is between 5,000 and 50,000 mIU/mL.
  • LDH is 1.5–10 times the upper limit of the normal range.
S3 At least one tumor marker level is very high.
  • AFP is higher than 10,000 ng/mL.
  • HCG is higher than 50,000 mIU/mL.
  • LDH is more than 10 times the upper limit of the normal range.

References

  1. Staging testicular cancer. Canadian cancer society 2016. http://www.cancer.ca/en/cancer-information/cancer-type/testicular/staging/?region=on. Accessed on February 26, 2016

Template:WH Template:WS